You have 9 free searches left this month | for more free features.

City

Tomsk (2)

Clermont-Ferrand (1)

Nimes (1)

Palo Alto (1)

Toulouse (1)

Condition

Primary Breast Cancer (2)

Breast Cancer Female (1)

Essential Tremor (1)

Fever of Unknown Origin (1)

Parkinson Disease (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (3)

phase 3 (2)

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences (3)

Carina Mari Aparici (1)

Zionexa (1)

Collaborator

Institute of Bioorganic Chemistry, Russian Academy of Sciences (1)

Uppsala University (1)

Intervention

spect (5)

67ga-citrate spect (1)

68ga-citrate pet/mri (1)

magnetic resonance imaging (1)

pet (1)

positron emission tomography (1)

Study Documents

Intervention Type

drug (5)

device (1)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (5)

spect

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Parkinson Disease, Essential Tremor Trial in Clermont-Ferrand, Nîmes, Toulouse (SPECT, PET)

Recruiting

Parkinson Disease
Essential Tremor

SPECT
PET

Clermont-Ferrand, France
+2 more

Aug 19, 2022

Primary Breast Cancer Trial (SPECT)

Not yet recruiting

Primary Breast Cancer

SPECT

(no location specified)

Jun 19, 2023

Breast Cancer Female Trial in Tomsk (SPECT)

Enrolling by invitation

Breast Cancer Female

SPECT

Tomsk, Russian Federation

TomskNRMC

Jan 21, 2022

Primary Breast Cancer Trial in Tomsk (SPECT)

Completed

Primary Breast Cancer

SPECT

Tomsk, Russian Federation

TomskNRMC

Oct 4, 2021

Fever of Unknown Origin Trial in Palo Alto (68Ga-Citrate PET/MRI, 67Ga-Citrate SPECT, Positron Emission Tomography)

Unknown status

Fever of Unknown Origin

68Ga-Citrate PET/MRI
+4 more

Palo Alto, California

Stanford University

Oct 23, 2019